Characterization of Beta-Lactam Resistome of Escherichia coli Causing Nosocomial Infections
Authors:
- Rosalino Vázquez-LópezRVRosalino Vázquez-López
- Tanya Hernández-MartínezTHTanya Hernández-Martínez
- Selene Ivonne Larios-FernándezSLSelene Ivonne Larios-Fernández
- Celia Piña-LeyvaCPCelia Piña-Leyva
- Manuel Lara-LozanoManuel Lara-Lozano
- Tayde Guerrero-GonzálezTGTayde Guerrero-González
- Javier Martínez-BautistaJMJavier Martínez-Bautista
- Eduardo Gómez-CondeEGEduardo Gómez-Conde
- Juan Antonio González-BarriosJGJuan Antonio González-Barrios
Open Access
- 23 August 2023
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 12 (9) , 1355
Abstract
Nosocomial infections caused by Escherichia coli pose significant therapeutic challenges due to the high expression of genes encoding antimicrobial drug resistance. In this study, we investigated the conformation of the beta-lactam resistome responsible for the specific pattern of resistance against beta-lactam antibiotics. A total of 218 Escherichia coli strains were isolated from in-hospital patients diagnosed with nosocomial infections, obtained from various sources such as urine (n = 49, 22.48%), vaginal discharge (n = 46, 21.10%), catheter tips (n = 14, 6.42%), blood (n = 13, 5.96%), feces (n = 12, 5.50%), sputum (n = 11, 5.05%), biopsies (n = 8, 3.67%), cerebrospinal fluid (n = 2, 0.92%) and other unspecified discharges (n = 63, 28.90%). To characterize the beta-lactam resistome, all strains were subjected to antibiotic dilution tests and grown in beta-lactam antibiotics supplemented with Luria culture medium. Subsequently, multiplex PCR and next-generation sequencing were conducted. The results show a multi-drug-resistance phenotype, particularly against beta-lactam drugs. The primary determinant of this resistance was the expression of the blaTEM gene family, with 209 positive strains (95.87%) expressing it as a single gene (n = 47, 21.6%) or in combination with other genes. Common combinations included blaTEM + blaCTX (n = 42, 19.3%), blaTEM + blaCTX + blaSHV (n = 13, 6%) and blaTEM + blaCTX + blaBIL (n = 12, 5.5%), among others. The beta-lactam resistome of nosocomial Escherichia coli strains isolated from inpatients at the “October first” Regional Hospital of ISSSTE was predominantly composed of members of the blaTEM gene family, expressed in various configurations along with different members of other beta-lactamase gene families.Keywords
Funding Information
- National Council for Science and Technology (CONACYT) Mexico (MOD.ORD./2012/SSA/IMSS/ISSSTE-CONACYT/000000000181384, 202324)
- Centro de Investigación en Ciencias de la Salud (CICSA) of Facultad de Ciencias de la Salud Universidad Anáhuac México Norte (MOD.ORD./2012/SSA/IMSS/ISSSTE-CONACYT/000000000181384, 202324)
This publication has 70 references indexed in Scilit:
- High Prevalence of bla CTX-M-1 Group Extended-Spectrum β-lactamase Genes in Escherichia coli Isolates From TehranJundishapur Journal of Microbiology, 2013
- blaCTX-M, blaTEM, and blaSHV in Enterobacteriaceae from North-Indian tertiary hospital: high occurrence of combination genesAsian Pacific Journal of Tropical Medicine, 2011
- Comparison of 61 Sequenced Escherichia coli GenomesMicrobial Ecology, 2010
- Characterization of Multidrug Resistant ESBL‐Producing Escherichia coli Isolates from Hospitals in MalaysiaBioMed Research International, 2009
- Evolution of extended-spectrum β-lactamases by mutationClinical Microbiology and Infection, 2008
- Biochemical Characterization of SFC-1, a Class A Carbapenem-Hydrolyzing β-LactamaseAntimicrobial Agents and Chemotherapy, 2007
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteriaFEMS Microbiology Letters, 2004
- Novel GES/IBC extended-spectrum ?-lactamase variants with carbapenemase activity in clinical enterobacteriaFEMS Microbiology Letters, 2004
- Influence of nosocomial infection on mortality rate in an intensive care unitCritical Care Medicine, 1994